These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 27884650)

  • 81. Venous thromboembolism in cancer: what is the optimal treatment?
    Posner J; Rizzolo D
    JAAPA; 2011 Aug; 24(8):44-9. PubMed ID: 21850919
    [No Abstract]   [Full Text] [Related]  

  • 82. Clotting and Bleeding in Oncology Patients: Clinical Scenarios and Challenges.
    Komatsubara KM; Diuguid DL
    Oncology (Williston Park); 2016 Oct; 30(10):936-40. PubMed ID: 27753062
    [No Abstract]   [Full Text] [Related]  

  • 83. Sex, gender and venous thromboembolism: do we care enough?
    Faioni EM; Zighetti ML; Vozzo NP
    Blood Coagul Fibrinolysis; 2018 Dec; 29(8):663-667. PubMed ID: 30234546
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Frequency of arterial thromboembolism in populations with malignancies: A systematic review.
    Yu J; Li A; Laureano M; Crowther M
    Thromb Res; 2019 Dec; 184():16-23. PubMed ID: 31678748
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Cancer risk after a venous thrombotic event - RIETE score.
    Mendonça JC; Martins J; Fernandes C; Carvalho C; Coutinho C; Cotter J
    Thromb Res; 2021 Jun; 202():43-44. PubMed ID: 33721801
    [No Abstract]   [Full Text] [Related]  

  • 86. Men with prostate cancer at higher risk of venous thromboembolism.
    Cancer; 2022 Oct; 128(20):3585. PubMed ID: 36161432
    [No Abstract]   [Full Text] [Related]  

  • 87. Is it time for a specific score for venous thromboembolism risk assessment for non-solid tumors?
    Macedo AVS; Ramacciotti E
    Chin Clin Oncol; 2019 Oct; 8(S1):S26. PubMed ID: 31684735
    [No Abstract]   [Full Text] [Related]  

  • 88. [Progress of malignant tumor associated venous thromboembolism].
    Yang J; Song Y
    Zhonghua Xue Ye Xue Za Zhi; 2014 Oct; 35(10):957-60. PubMed ID: 25339340
    [No Abstract]   [Full Text] [Related]  

  • 89. [Computerized registry of patients with thromboembolic disease in Spain (RIETE): background, objectives, methods, and preliminary results].
    Suárez Fernández C; González-Fajardo JA; Monreal Bosch M;
    Rev Clin Esp; 2003 Feb; 203(2):68-73. PubMed ID: 12605778
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The value of collecting population-based cancer stage data to support decision-making at organizational, regional and population levels.
    Brierley JD; Srigley JR; Yurcan M; Li B; Rahal R; Ross J; King MJ; Sherar M; Skinner R; Sawka C
    Healthc Q; 2013; 16(3):27-33. PubMed ID: 24034774
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Efficacy and safety of bemiparin as treatment of venous thromboembolic disease in the elderly.
    Ena J; Stanimirova-Nikolova S; Iborra-Devesa M; Raya-Santos C; Serra-Manclus A; Seco-Hanselaar IJ
    J Eval Clin Pract; 2024 Sep; 30(6):1084-1090. PubMed ID: 38798183
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [What is the treatment duration after a venous thromboembolic event?].
    Couturaud F; Mahé I
    Rev Med Interne; 2018 Nov; 39(11):839-841. PubMed ID: 29754698
    [No Abstract]   [Full Text] [Related]  

  • 93. Of matters great and small.
    Versteeg HH; Rodger M
    Thromb Res; 2017 Feb; 150():101. PubMed ID: 28137540
    [No Abstract]   [Full Text] [Related]  

  • 94. Predictors of active cancer thromboembolic outcomes: role of body composition.
    Iftikhar O; Silva-Palacios F; Cherry M; Mansfield A; Stoner J; Tafur A
    Int Angiol; 2017 Feb; 36(1):88-89. PubMed ID: 28124878
    [No Abstract]   [Full Text] [Related]  

  • 95. [Unprovoked venous thromboembolism: Should we be looking for cancer?].
    Larsen TB
    Ugeskr Laeger; 2015 Nov; 177(48):V67480. PubMed ID: 26617165
    [No Abstract]   [Full Text] [Related]  

  • 96. Lung, breast, and colorectal cancer: the relationship between extent of disease and age at diagnosis.
    Mor V; Guadagnoli E; Masterson-Allen S; Silliman R; Glicksman AS; Cummings FJ; Goldberg RJ; Fretwell MD
    J Am Geriatr Soc; 1988 Oct; 36(10):873-6. PubMed ID: 3171026
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Navigating venous thromboembolism risks in lung cancer patients.
    Chiu SV; Hung CM; Chen JR; Yeh LR; Chiu CC
    Thorac Cancer; 2024 May; 15(14):1195-1196. PubMed ID: 38567710
    [No Abstract]   [Full Text] [Related]  

  • 98. Neurologic and Medical Management of Brain Tumors.
    Phillips KA; Fadul CE; Schiff D
    Neurol Clin; 2018 Aug; 36(3):449-466. PubMed ID: 30072065
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Venous thromboembolism in cancer clinical trials: recommendation for standardized reporting and analysis.
    Carrier M; Khorana AA; Zwicker JI; Lyman GH; Le Gal G; Lee AY;
    J Thromb Haemost; 2012 Dec; 10(12):2599-601. PubMed ID: 23362524
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.